What’s Next?
With both boards unanimously approving the deal, all eyes now turn to potential competing bids during the go-shop window. But whether another suitor steps forward or not, one thing is clear: ArchiMed is betting big on the future of dental health—and it’s a bet Wall Street is watching closely.
